SOPHiA GENETICS (SOPH) Accounts Payables (2020 - 2025)

SOPHiA GENETICS has disclosed Accounts Payables across 6 years of filings, most recently posting $9.0 million for Q4 2025.

• Accounts Payables for Q4 2025 came in at $9.0 million, up 71.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.0 million (up 71.65% YoY), and the FY2025 annual result was $9.0 million, up 71.65% from the prior year.
• Accounts Payables came in at $9.0 million for Q4 2025 at SOPHiA GENETICS, up from $6.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $9.0 million in Q4 2025 to a low of $4.6 million in Q1 2025.
• The 5-year median for Accounts Payables is $6.2 million (2024), against an average of $6.5 million.
• Across the five-year window, Accounts Payables tumbled 35.93% in 2022 and soared 71.65% in 2025, its largest moves.
• SOPHiA GENETICS's Accounts Payables stood at $6.7 million in 2021, then retreated by 8.25% to $6.2 million in 2022, then retreated by 12.78% to $5.4 million in 2023, then fell by 3.17% to $5.2 million in 2024, then jumped by 71.65% to $9.0 million in 2025.
• The last three Accounts Payables figures came in at $9.0 million (Q4 2025), $6.1 million (Q3 2025), and $7.7 million (Q2 2025), per Business Quant data.